MALVERN, Pa. & STAFFORD, England--(BUSINESS WIRE)--PuriCore (LSE: PURI), the life sciences company focused on the development and commercialization of its novel, safe antimicrobial technology, will present results of several recent studies showing that its Sterilox Solution effectively decontaminates hard surfaces infected with norovirus, methicillin-resistant Staphylococcus aureus (MRSA), Acinetobacter, and human influenza—all considered major outbreak pathogens—at the National Environmental Health Association Conference (NEHA) this week. The Sterilox Solution, which mimics the natural anti-microbial hypochlorous acid produced by the human body to fight pathogens, is used in a broad range of markets that depend upon controlling contamination, including food safety, medical device disinfection, wound management, and hospitality.
